Fertify®
Fertify® is the genetic test for assessing female risk for early menopause and age-related infertility.
Fertify® test is recommended for women at any age, preferably until late thirties, before the age-related decline of fertility; women planning for infertility treatment, including in vitro fertilization (IVF); women planning for oocyte freezing. Fertify® test can be a helpful tool in family planning, as advanced maternal age and later family forming are rather increasing trend.
Original price was: € 220.00.€ 195.00Current price is: € 195.00.
Description
Fertify: Your Genetic Insight into Fertility and Reproductive Health
Fertify is a groundbreaking genetic test designed to assess a woman’s risk of early menopause and age-related infertility. This test provides valuable insights into reproductive aging, offering personalized recommendations to support informed family planning and fertility preservation.
Who Should Consider the Fertify Test?
Women of any age, ideally before their late thirties, when age-related fertility decline accelerates.
Women planning infertility treatments, including in vitro fertilization (IVF).
Women considering oocyte (egg) freezing for future family planning.
Why Take the Fertify Test?
Reproductive aging is largely influenced by genetics, with hundreds of DNA variants affecting a woman’s reproductive lifespan. Fertify offers a comprehensive evaluation of these factors, enabling you to make proactive decisions based on your unique genetic risk.
What Does the Test Include?
The results provide tailored guidance on:
Enhancing natural fertility through lifestyle and medical interventions.
Recommended medical examinations and diagnostic tests.
Egg freezing and fertility preservation options.
Assisted reproductive technologies, such as IVF, if necessary.
Key Insights into Female Fertility:
Fertility typically begins to decline 10-20 years before menopause, leading to challenges with conception.
While the average age of menopause is 50-51, approximately 1 in 20 women experience early menopause (before 45), and 1 in 100 face premature menopause (before 40).
Early and premature menopause are significant contributors to age-related infertility, making early assessment critical.
Turnaround Time: 15 working days
Specimen Requirements: Buccal cell sample
